Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
about
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast CancerThe LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.Characterization of a Novel Anti-Human HB-EGF Monoclonal Antibody Applicable for Paraffin-Embedded Tissues and Diagnosis of HB-EGF-Related Cancers.Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.Roles of LPA receptor signaling in breast cancer.The Expression of Hippocampal NRG1/ErbB4 Correlates With Neuronal Apoptosis, but Not With Glial Activation During Chronic Cerebral Hypoperfusion.
P2860
Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Identification of heparin-bind ...... n breast and prostate cancers.
@ast
Identification of heparin-bind ...... n breast and prostate cancers.
@en
type
label
Identification of heparin-bind ...... n breast and prostate cancers.
@ast
Identification of heparin-bind ...... n breast and prostate cancers.
@en
prefLabel
Identification of heparin-bind ...... n breast and prostate cancers.
@ast
Identification of heparin-bind ...... n breast and prostate cancers.
@en
P2093
P2860
P50
P1433
P1476
Identification of heparin-bind ...... n breast and prostate cancers.
@en
P2093
Florence Mege
Françoise Descotes
Johnny Ribeiro
Marion David
Raphaël Leblanc
P2860
P304
P356
10.1371/JOURNAL.PONE.0097771
P407
P577
2014-05-14T00:00:00Z